The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
Wanted: Scientific Standard for Hospital Cleaning
NLCS Strengthens Safety and Compliance with Comprehensive Electrical Program
Sun Valley Surgery Center Suffers a Data Breach
EV Charging Stations: Planning for Safety, Convenience, Expansion
Why Ambulatory Surgery Centers Are Turning to Dedicated HVAC Systems